| Primary |
| Depression |
37.7% |
| Product Used For Unknown Indication |
13.4% |
| Insomnia |
12.7% |
| Constipation |
4.9% |
| Renal Failure Chronic |
3.7% |
| Angina Pectoris |
3.4% |
| Anxiety |
3.0% |
| Hypertension |
3.0% |
| Prostate Cancer |
3.0% |
| Gastritis |
2.6% |
| Disease Complication |
1.9% |
| Dyslipidaemia |
1.5% |
| Intraocular Pressure Increased |
1.5% |
| Altered State Of Consciousness |
1.1% |
| Anxiety Disorder |
1.1% |
| Cardiac Failure |
1.1% |
| Diabetes Mellitus |
1.1% |
| Mania |
1.1% |
| Parkinson's Disease |
1.1% |
| Sleep Disorder |
1.1% |
|
| Convulsion |
11.8% |
| Suicide Attempt |
9.8% |
| Completed Suicide |
7.8% |
| Intentional Overdose |
7.8% |
| Neuroleptic Malignant Syndrome |
7.8% |
| Pneumonia |
5.9% |
| Serotonin Syndrome |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Drug Eruption |
3.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.9% |
| Inappropriate Antidiuretic Hormone Secretion |
3.9% |
| Liver Disorder |
3.9% |
| Loss Of Consciousness |
3.9% |
| Overdose |
3.9% |
| Somnolence |
3.9% |
| Altered State Of Consciousness |
2.0% |
| Atrioventricular Block |
2.0% |
| Blood Lactate Dehydrogenase Increased |
2.0% |
| Blood Potassium Increased |
2.0% |
| Cardiac Arrest |
2.0% |
|
| Secondary |
| Depression |
37.3% |
| Renal Failure Chronic |
16.5% |
| Product Used For Unknown Indication |
10.7% |
| Insomnia |
9.3% |
| Disease Complication |
4.1% |
| Intraocular Pressure Increased |
3.3% |
| Anxiety |
2.7% |
| Constipation |
2.5% |
| Diabetic Complication |
1.6% |
| Prostate Cancer |
1.6% |
| Gastritis |
1.4% |
| Hypertension |
1.4% |
| Diabetes Mellitus |
1.2% |
| Dyslipidaemia |
1.2% |
| Atrial Fibrillation |
0.8% |
| Depressive Symptom |
0.8% |
| Diabetic Neuropathy |
0.8% |
| Drug Level |
0.8% |
| Gastric Cancer |
0.8% |
| Hyperlipidaemia |
0.8% |
|
| Convulsion |
27.1% |
| Intraocular Pressure Increased |
5.7% |
| Liver Disorder |
5.7% |
| Overdose |
5.7% |
| Sudden Death |
5.7% |
| Suicide Attempt |
5.7% |
| Transient Ischaemic Attack |
5.7% |
| Drug Eruption |
4.3% |
| Malaise |
4.3% |
| Completed Suicide |
2.9% |
| Depression |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.9% |
| Hypersomnia |
2.9% |
| Intentional Overdose |
2.9% |
| Myopathy |
2.9% |
| Parkinson's Disease |
2.9% |
| Respiratory Failure |
2.9% |
| Status Epilepticus |
2.9% |
| Weight Increased |
2.9% |
| Altered State Of Consciousness |
1.4% |
|
| Concomitant |
| Chronic Hepatitis C |
15.0% |
| Depression |
13.7% |
| Hypertension |
9.3% |
| Insomnia |
8.8% |
| Hepatitis C |
6.2% |
| Metastatic Renal Cell Carcinoma |
4.9% |
| Prophylaxis |
4.9% |
| Bipolar Disorder |
4.4% |
| Constipation |
4.0% |
| Spinal Osteoarthritis |
3.5% |
| Pruritus |
3.1% |
| Pyrexia |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Extradural Abscess |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Attention Deficit/hyperactivity Disorder |
2.2% |
| Breast Cancer |
2.2% |
| Diabetes Mellitus |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Anxiety Disorder |
1.8% |
|
| Completed Suicide |
10.5% |
| Renal Disorder |
7.9% |
| Rheumatoid Arthritis |
7.9% |
| Subarachnoid Haemorrhage |
7.9% |
| White Blood Cell Count Decreased |
7.9% |
| Hypertriglyceridaemia |
5.3% |
| Hypoglycaemia |
5.3% |
| Intentional Drug Misuse |
5.3% |
| Off Label Use |
5.3% |
| Restlessness |
5.3% |
| Retinopathy |
5.3% |
| Thoracic Cavity Drainage |
5.3% |
| Asthma |
2.6% |
| Atrioventricular Block |
2.6% |
| Back Pain |
2.6% |
| Blood Triglycerides Increased |
2.6% |
| Condition Aggravated |
2.6% |
| Depression |
2.6% |
| Diplopia |
2.6% |
| Drug Eruption |
2.6% |
|
| Interacting |
| Depression |
50.0% |
| Sleep Disorder |
50.0% |
|
| Serotonin Syndrome |
100.0% |
|
